Intersect ENT today announced that it has launched its Straight Delivery System with its Propel Mini Sinus Implant.
The combination packaging originally received FDA premarket approval in July 2020. The Straight Delivery System (SDS) is an extension of Intersect ENT’s Propel family of implants that is engineered for precise, consistent and easy delivery of the Propel Mini Implant into the ethmoid sinus for maximum tissue apposition.
Intersect ENT’s original curved delivery system will continue to be available with the Propel Mini.
“Intersect ENT is pleased to provide our physicians with a complete package of PROPEL Mini and the Straight Delivery System,” president and CEO Thomas West said. “We are dedicated to responding to our customers’ feedback and providing them with the best combination of products to advance care for chronic sinusitis patients in various centers of care.”
“The combination of the PROPEL Mini and the Straight Delivery System in one package is reflective of Intersect ENT’s ongoing commitment to supporting the ENT community,” Roheen Raithatha, a practicing rhinologist in New York, said. “I look forward to utilizing this newly bundled implant and delivery system during my FESS procedures.”